Retron Probiotics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 20-12-2024
- Paid Up Capital ₹ 0.50 M
as on 20-12-2024
- Company Age 7 Year, 2 Months
- Last Filing with ROC 31 Mar 2022
- Revenue -63.27%
(FY 2022)
- Profit -75.65%
(FY 2022)
- Ebitda -59.37%
(FY 2022)
- Net Worth 11.14%
(FY 2022)
- Total Assets -20.84%
(FY 2022)
About Retron Probiotics
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Swami Bobba and Venkayamma Attaluri serve as directors at the Company.
- CIN/LLPIN
U51909AP2017PTC106769
- Company No.
106769
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Sep 2017
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Krishna, Andhra Pradesh, India
- Telephone
- Email Address
- Social Media
What products or services does Retron Probiotics Private Limited offer?
Retron Probiotics Private Limited offers a wide range of products and services, including Cosmetics, Hair & Beauty Products, Skin Care Cosmetics, Process Control Systems & Equipments, Limit Controller, Industrial Chemicals & Supplies, Water Treatment Chemicals, Fertilizers and Soil Additives, Plant Growth Promoters, Digestive System Drugs & Medicines, Pre & Probiotic Capsule.
Who are the key members and board of directors at Retron Probiotics?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Swami Bobba  | Managing Director | 29-Sep-2017 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venkayamma Attaluri | Director | 29-Sep-2017 | Current |
Financial Performance of Retron Probiotics.
Retron Probiotics Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 63.27% decrease. The company also saw a substantial fall in profitability, with a 75.65% decrease in profit. The company's net worth Soared by an impressive increase of 11.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Retron Probiotics?
In 2022, Retron Probiotics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Retron Probiotics?
Unlock and access historical data on people associated with Retron Probiotics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Retron Probiotics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Retron Probiotics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
